TOP1 and cancer: Strategies to modify chemical structures of TOP1 inhibitors to generate stabilized and persistent TOP1cc showed enhanced sensitivity of cancer cells in vitro and in vivo (Crawley et al., 2015; Kundu et al., 2019).